Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 876 of 1,261
  1. US 8420619

    Rescue of photoreceptors by intravitreal administration of an expression vector encoding a therapeutic protein

    Ceregene, Inc. · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted
  2. US 8420596

    Macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted
  3. US 8420068

    Polymer-based compositions and conjugates of antimicrobial agents

    Nektar Therapeutics · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted
  4. US 8420072

    Vaccination of sex reversed hybrid tilapia (Oreochromis niloticus x O. aureus) with an inactivated Vibrio vulnificus vaccine

    The United States of America, as represented by the Secretary of Agriculture · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted
  5. US 8420686

    Linked diimidazole antivirals

    Enanta Pharmaceuticals, Inc. · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted
  6. US 8420612

    Diabetes treatment methods and drug targets therefor

    The Regents of the University of California · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted
  7. US 8420607

    Anthrax carbohydrates, synthesis and uses thereof

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted
  8. US 8420368

    Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof

    BIOMARIN PHARMACEUTICAL INC. · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted
  9. US 8420099

    Chimeric protein for prevention and treatment of HIV infection

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted
  10. US 8420107

    Peptide vaccines against group A streptococci

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted
  11. US 8420694

    Pyrrolidin-2-one derivatives as androgen receptor modulator

    Takeda Pharmaceutical Company Limited · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted
  12. US 8420665

    Anti-cancer compounds

    Northwestern University · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted
  13. US 8420664

    A3 adenosine receptor allosteric modulators

    THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPT. HEALTH & HUMAN SERVICES · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted
  14. US 8420659

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted
  15. US 8420852

    Phospholipase A2 inhibitors and their use in treating neurological injury and disease

    The Regents of the University of California · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted
  16. US 8420669

    Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the BETA2 adrenergic receptor

    Laboratories Almirall, S.A. · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted
  17. US 8420816

    Dihydropyrrolonaphthyridinone compounds as inhibitors of JAK

    Takeda Pharmaceutical Company Limited · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted
  18. US 8420885

    Determining the capability of a test compound to affect solid tumor stem cells

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted
  19. US 8420799

    Therapeutic compositions

    Alnylam Pharmaceuticals, Inc. · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted
  20. US 8420678

    Small molecule inhibitors of the pleckstrin homology domain and methods for using same

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted
  21. US 8420650

    Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP)

    BIOMARIN PHARMACEUTICAL INC. · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted
  22. US 8420620

    Induced internalization of surface receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted
  23. DE 102011115690

    Quetiapin enthaltende Formulierungen

    ACINO PHARMA AG [CH] · Granted Apr 11, 2013 · Expires Apr 6, 2033

    granted
  24. DE 102011114864

    Verfahren zur Herstellung einer homogenen Pulvermischung und Verfahren zur Herstellung eines Implantats sowie Implantat

    ACINO AG [DE] · Granted Apr 11, 2013 · Expires Apr 6, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.